Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
4,717.10Prev. Close
4,717.10Volume
12,903Total traded value
5.99 CrUpper Circuit
5,571.10Lower Circuit
3,714.10Fundamentals
| Market Cap | ₹10,696Cr |
| ROE | 77.82% |
| P/E Ratio(TTM) | 53.48 |
| EPS(TTM) | 86.84 |
| P/B Ratio | 41.61 |
| Dividend Yield | 1.18% |
| Industry P/E | 40.38 |
| Book Value | 111.60 |
| Debt to Equity | 0.11 |
| Face Value | 10 |
Understand Fundamentals
Financials
About Sanofi Consumer Healthcare India
As a leading player in India's consumer healthcare space, the company offers trusted, science-backed solutions through brands like Allegra, Combiflam, and Avil. Its core mission is to empower consumers by making self-care as simple as it should be, putting health directly into their hands. Demonstrating significant market strength, the company sold 117 strips of its popular Combiflam brand every single minute throughout 2023.;
| Parent Organisation | Sanofi Consumer Healthcare India |
| NSE Symbol | SANOFICONR |
Shareholding Pattern
Oct '24
Dec '24
Mar '25
Jun '25
Sep '25
Top Mutual Funds Invested(4)
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Abbott India | NA (0.00%) | 40.56 | ||
| GlaxoSmithKline Pharmaceuticals | NA (0.00%) | 45.94 | ||
| Pfizer | NA (0.00%) | 28.69 | ||
| Astrazeneca Pharma India | NA (0.00%) | 123.79 |